Nemera Szczecin Sp. z o.o.

Nemera Szczecin, subsidiary of French group Nemera (formerly Copernicus, acquired 2020), specializes in the design, development and manufacturing of injectable drug delivery devices (disposable pen injectors for GLP-1 and more). In January 2023 it inaugurated a BREEAM-certified 11,000 m² plant with 3,400 m² cleanroom in Szczecin. Targeting 350 employees, currently ~120 staff, expanding capacity for the GLP-1 market.